Results 61 to 70 of about 28,111,627 (303)

Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]

open access: yesJournal of the Pediatric Infectious Diseases Society, 2020
Abstract Over 100 attempts are being made to develop a vaccine for use in the epidemic of COVID-19. Many different technologies are being used in an effort to prevent the infection or at least the disease.
openaire   +2 more sources

Role of natural drugs in severe acute respiratory syndrome coronavirus 2: potential beneficial effects in prevention or prior treatment in elderly and cancer patients

open access: yesGeriatric Care, 2020
In 2019, a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world. It causes an acute respiratory disease, by involving the same receptor, i.e. the angiotensin-converting enzyme 2, as that
Eugenio Boccalone   +2 more
doaj   +1 more source

Acute pericarditis and severe acute respiratory syndrome coronavirus 2: Case report [PDF]

open access: yesInternational Journal of Infectious Diseases, 2020
We present the case of a 51-year-old patient with acute pericarditis as the dominant manifestation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The patient was admitted to the emergency department during a coronavirus disease 2019 (COVID-19) outbreak with a suspected ST-elevation myocardial infarction. A coronary angiogram
Blagojevic, Nikola R.   +5 more
openaire   +3 more sources

Human monoclonal antibody combination against SARS coronavirus : synergy and coverage of escape mutants [PDF]

open access: yes, 2006
Background: Experimental animal data show that protection against severe acute respiratory syndrome coronavirus (SARS-CoV) infection with human monoclonal antibodies (mAbs) is feasible.
Peiris, Joseph S. M.   +73 more
core   +1 more source

SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA

open access: yesEmerging Infectious Diseases, 2021
We report persistent severe acute respiratory syndrome coronavirus 2 infection in a patient with HIV/AIDS; the virus developed spike N terminal domain and receptor binding domain neutralization resistance mutations.
Seth A. Hoffman   +13 more
doaj   +1 more source

Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome [PDF]

open access: yes, 2007
The severe acute respiratory syndrome coronavirus (SARS-CoV) genome is predicted to encode 14 functional open reading frames, leading to the expression of up to 30 structural and non-structural protein products.
Brunn, Albrecht von   +31 more
core   +1 more source

Bilateral basal ganglia ischemia associated with COVID-19: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2021
Background Coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus 2, has a broad clinical spectrum, from asymptomatic to multi-organ dysfunction.
Khurram Khaliq Bhinder   +5 more
doaj   +1 more source

Epidemiological and genetic analysis of severe acute respiratory syndrome.

open access: yes, 2004
The severe acute respiratory syndrome (SARS) epidemics in 2002-2003 showed how quickly a novel infectious disease can spread both within communities and internationally.
Fisher, Matthew C   +13 more
core   +1 more source

SARS-CoV antibody prevalence in all Hong Kong patient contacts. [PDF]

open access: yes, 2004
A total of 1,068 asymptomatic close contacts of patients with severe acute respiratory (SARS) from the 2003 epidemic in Hong Kong were serologically tested, and 2 (0.19%) were positive for SARS coronavirus immunoglobulin G antibody. SARS rarely manifests
Law, Y-L   +63 more
core   +1 more source

Ezrin interacts with the SARS coronavirus spike protein and restrains infection at the entry stage [PDF]

open access: yes, 2012
© 2012 Millet et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
Béatrice Nal   +66 more
core   +1 more source

Home - About - Disclaimer - Privacy